Chris Simpson counsels clients regarding a wide range of transactional and corporate law matters. With a particular focus on the life sciences space, Chris advises clients across the spectrum – from growth-oriented companies to venture and growth equity funds – on significant mergers, acquisitions, strategic collaborations and similar transactions as well as day to day operative and commercial matters.
Corporate & Transactional
Chris represents and advises public and private companies in a variety of industries in mergers and acquisitions, securities law compliance issues, equity financings and general corporate governance work.
Chris advises life sciences companies from start-up stage to public companies on various corporate matters including negotiating investments, mergers and acquisitions, strategic collaborations and joint ventures and public offerings. Chris also assists life sciences companies with day-to-day corporate and business development strategies.
Venture Capital and Growth Equity
Chris counsels venture capital and growth equity funds in connection with their debt and equity financing investments in private companies.
A large portion of Chris’ experience has involved cross-border transactions in the life sciences space, including cross-border acquisitions, financings, joint ventures and collaborations
Before Polsinelli, Chris practiced at Choate, Hall & Stewart, LLP in Boston Massachusetts.